These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18510690)

  • 1. Von Willebrand disease and angiodysplasia responding to atorvastatin.
    Sohal M; Laffan M
    Br J Haematol; 2008 Jun; 142(2):308-9. PubMed ID: 18510690
    [No Abstract]   [Full Text] [Related]  

  • 2. Von Willebrand disease, angiodysplasia and atorvastatin.
    Alikhan R; Keeling D
    Br J Haematol; 2010 Apr; 149(1):159-60. PubMed ID: 19995387
    [No Abstract]   [Full Text] [Related]  

  • 3. Atorvastatin.
    Hyatt PJ
    Br J Hosp Med; 1997 Oct 1-14; 58(7):333-6. PubMed ID: 9509055
    [No Abstract]   [Full Text] [Related]  

  • 4. Atorvastatin + amlodipine: new drug. Just a commercial ploy.
    Prescrire Int; 2007 Jun; 16(89):105. PubMed ID: 17582926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too].
    MMW Fortschr Med; 2005 Aug; 147(33-34):51. PubMed ID: 16138641
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of the efficacy of statin therapy in dyslipidemic diseases such as combined hypercholesterolemia IIA and hyperlipidemia].
    Liguori E; Sarcinella R
    Minerva Cardioangiol; 1998 Sep; 46(9):317-8. PubMed ID: 10021861
    [No Abstract]   [Full Text] [Related]  

  • 7. [Coronary disease patient has already LDL of 100 mg/dl. Why lipid lowering is still worthwhile].
    MMW Fortschr Med; 2005 Mar; 147(12):4. PubMed ID: 15832778
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute effect of atorvastatin on coronary circulation measured by transthoracic Doppler echocardiography in patients without coronary artery disease by angiography.
    Hinoi T; Matsuo S; Tadehara F; Tsujiyama S; Yamakido M
    Am J Cardiol; 2005 Jul; 96(1):89-91. PubMed ID: 15979441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease.
    Conard SE; Bays HE; Leiter LA; Bird SR; Rubino J; Lowe RS; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2008 Dec; 102(11):1489-94. PubMed ID: 19026302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lowering of cholesterol. What role is played by the choice of statins?].
    März W
    MMW Fortschr Med; 2004 Sep; 146(35-36):55. PubMed ID: 15540544
    [No Abstract]   [Full Text] [Related]  

  • 11. Rigorous detection and vigorous treatment of familial hypercholesterolaemia.
    Durrington PN
    Lancet; 2001 Feb; 357(9256):574-5. PubMed ID: 11558479
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of ezetimibe added on to atorvastatin (40 mg) compared with uptitration of atorvastatin (to 80 mg) in hypercholesterolemic patients at high risk of coronary heart disease.
    Leiter LA; Bays H; Conard S; Bird S; Rubino J; Hanson ME; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2008 Dec; 102(11):1495-501. PubMed ID: 19026303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [For coronary disease patients is certain: the lower the LDL the better].
    MMW Fortschr Med; 2006 Jun; 148(24):6. PubMed ID: 16850797
    [No Abstract]   [Full Text] [Related]  

  • 14. The comparison of the effects of standard 20 mg atorvastatin daily and 20 mg atorvastatin every other day on serum LDL-cholesterol and high sensitive C-reactive protein levels.
    Keleş T; Akar Bayram N; Kayhan T; Canbay A; Sahin D; Durmaz T; Ozdemir O; Aydoğdu S; Diker E
    Anadolu Kardiyol Derg; 2008 Dec; 8(6):407-12. PubMed ID: 19103535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Von Willebrand's disease and angiodysplasia treated with thalidomide.
    Hirri HM; Green PJ; Lindsay J
    Haemophilia; 2006 May; 12(3):285-6. PubMed ID: 16643215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of atorvastatin in treating high risk patients to reach low density lipoprotein-cholesterol goals: the Treat to Target (TTT-Israel) Study.
    Leibovitz E; Harats D; Gavish D
    Isr Med Assoc J; 2002 Jun; 4(6):407-10. PubMed ID: 12073409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
    Illingworth DR; Crouse JR; Hunninghake DB; Davidson MH; Escobar ID; Stalenhoef AF; Paragh G; Ma PT; Liu M; Melino MR; O'Grady L; Mercuri M; Mitchel YB;
    Curr Med Res Opin; 2001; 17(1):43-50. PubMed ID: 11464446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute pancreatitis possibly associated with combined salicylate and atorvastatin therapy.
    Miltiadous G; Anthopoulou A; Elisaf M
    JOP; 2003 Jan; 4(1):20-1. PubMed ID: 12555012
    [No Abstract]   [Full Text] [Related]  

  • 19. Atorvastatin versus revascularization treatment (AVERT): fact or fancy?
    Singh BM; Puri S; Saucedo J; Talley JD
    Am Heart J; 2000 Jul; 140(1):6-9. PubMed ID: 10874254
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study.
    Kinlay S; Schwartz GG; Olsson AG; Rifai N; Sasiela WJ; Szarek M; Ganz P; Libby P;
    Circulation; 2004 Jul; 110(4):386-91. PubMed ID: 15262833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.